GO:0046034 ATP metabolic process: Energy Currency Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046034 ATP metabolic process describes all chemical reactions and pathways involving ATP, the universal coenzyme and enzyme regulator.
• ATP is synthesized primarily through glycolysis, oxidative phosphorylation, and substrate-level phosphorylation, and is consumed by ATPases, kinases, and biosynthetic reactions.
• Dysregulated ATP metabolism is a hallmark of cancer, where tumor cells often shift to aerobic glycolysis (Warburg effect) to support rapid ATP production and biosynthesis.
• Key genes in ATP metabolism include glycolytic enzymes (HK2, PFKM, PKM), mitochondrial ATP synthase (ATP5F1A, ATP5F1B), and ATP-consuming enzymes such as Na+/K+-ATPase (ATP1A1).
• ATP metabolic process is tightly regulated by energy sensors (AMPK, mTOR) and substrate availability, and is essential for insulin secretion, immune cell function, and thermogenesis.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of ATP metabolic genes in health and disease.
Description
Adenosine triphosphate (ATP) is the principal energy currency of the cell, and the set of reactions that synthesize, utilize, and regenerate ATP is collectively termed ATP metabolic process (GO:0046034). This biological process encompasses glycolysis, oxidative phosphorylation, substrate-level phosphorylation, and the myriad of ATP-consuming reactions that drive cellular work, from ion transport to macromolecular synthesis. Because ATP is also a signaling molecule and an allosteric regulator of enzymes, its metabolism is intimately linked to cellular decision-making, proliferation, and survival. Researchers study ATP metabolic process to understand how cells balance energy supply and demand, how metabolic reprogramming contributes to diseases such as cancer and diabetes, and how to manipulate ATP pools for therapeutic or biotechnological purposes. The QuickGO definition emphasizes that ATP metabolic process includes the chemical reactions and pathways involving ATP, a universally important coenzyme and enzyme regulator. This article provides a research-grade overview of the genes, mechanisms, disease links, and experimental models relevant to GO:0046034.
ATP metabolic process At A Glance
| GO ID | GO:0046034 |
|---|---|
| GO term | ATP metabolic process |
| Ontology | biological_process |
| Synonym | ATP metabolism |
| Major function | Synthesis, utilization, and regeneration of ATP as the universal energy currency and enzyme regulator |
| Key pathways | Glycolysis, oxidative phosphorylation, substrate-level phosphorylation, ATP hydrolysis |
| Key enzymes | Hexokinase 2 (HK2), phosphofructokinase (PFKM), pyruvate kinase M (PKM), ATP synthase (ATP5F1A/B), Na+/K+-ATPase (ATP1A1) |
| Regulation | Energy sensors (AMPK, mTOR), substrate availability, oxygen tension, and hormonal signals |
| Disease relevance | Cancer, diabetes, obesity, neurodegenerative disorders, and inflammatory diseases |
What Is GO:0046034?
ATP metabolic process (GO:0046034) is defined by QuickGO as the chemical reactions and pathways involving ATP, adenosine triphosphate, a universally important coenzyme and enzyme regulator. In practice, this includes both the generation of ATP (catabolic pathways such as glycolysis, the tricarboxylic acid cycle, and oxidative phosphorylation) and the utilization of ATP (anabolic reactions, ion pumping, kinase-mediated phosphorylation, and regulatory processes). The term also covers the interconversion of ATP with ADP and AMP, and the role of ATP as a phosphate donor and allosteric effector.
Why Is ATP metabolic process Important in Cell Biology?
ATP metabolic process is fundamental to all life because ATP is the primary energy currency that powers cellular work, from muscle contraction to protein synthesis. Its dysregulation is a common feature of many diseases: cancer cells often reprogram ATP metabolism to support rapid growth and survival, while defects in insulin secretion and thermogenesis are linked to metabolic disorders such as diabetes and obesity. Moreover, ATP metabolism intersects with immune cell function, as one-carbon metabolism supports S-adenosylmethionine and histone methylation in inflammatory macrophages. Understanding ATP metabolic process therefore provides insights into basic cell biology and offers therapeutic targets for a wide range of pathologies.
• ATP is the universal energy currency, required for biosynthesis, transport, and motility.
• Glycolytic and oxidative phosphorylation pathways are frequently rewired in cancer, making ATP metabolism a target for therapy.
• ATP-sensitive potassium channels and ATP metabolism are critical for glucose-stimulated insulin secretion in pancreatic beta cells.
• Purinergic crosstalk between adipocytes and macrophages influences thermogenic brown adipose tissue degeneration, linking ATP metabolism to obesity.
• One-carbon metabolism supports ATP-dependent processes such as histone methylation in inflammatory macrophages.
• Wild-type IDH2 supports ATP production and is a therapeutic target in triple-negative breast cancer.
• Manipulation of the ATP pool is a tool for metabolic engineering in biotechnology.
• Electron bifurcation is an ancient energy-coupling mechanism that contributes to ATP synthesis in microbes.
• ATP metabolic process is essential for neuronal function and survival, and its failure contributes to neurodegeneration.
• CRISPR screens targeting ATP metabolic genes can identify vulnerabilities in specific cancer contexts.
What Happens During ATP metabolic process?
Glycolysis and substrate-level phosphorylation
In simple terms: Cells break down glucose to make a small amount of ATP quickly, without needing oxygen.
Glycolysis converts glucose to pyruvate, generating a net of two ATP molecules per glucose via substrate-level phosphorylation. This pathway is upregulated in many cancer cells, a phenomenon known as the Warburg effect, which supports rapid ATP production and biosynthetic precursors. Key enzymes such as hexokinase 2 (HK2), phosphofructokinase (PFKM), and pyruvate kinase M (PKM) are often overexpressed in tumors and are considered therapeutic targets.
Oxidative phosphorylation and mitochondrial ATP synthesis
In simple terms: Mitochondria use oxygen to produce large amounts of ATP through a molecular turbine called ATP synthase.
Oxidative phosphorylation couples electron transport to proton pumping across the inner mitochondrial membrane, generating a proton gradient that drives ATP synthase (complex V) to produce ATP. The enzyme ATP5F1A (alpha subunit) and ATP5F1B (beta subunit) are core components of the catalytic domain. Electron bifurcation is an ancient mechanism that enhances energy conservation in some microbes and contributes to ATP synthesis. In cancer, mitochondrial ATP production can be maintained by wild-type IDH2, which supports redox balance and ATP generation.
ATP hydrolysis and cellular work
In simple terms: ATP is broken down into ADP and phosphate to release energy for cellular activities.
ATP hydrolysis powers ion pumps (e.g., Na+/K+-ATPase, encoded by ATP1A1), muscle contraction, and kinase reactions that phosphorylate proteins and metabolites. The hydrolysis of ATP to ADP and inorganic phosphate is coupled to endergonic processes, and the ratio of ATP to ADP/AMP serves as a key indicator of cellular energy status. ATP also acts as an allosteric regulator of enzymes, influencing metabolic flux.
Regulation of ATP pools and energy sensing
In simple terms: Cells monitor ATP levels and adjust production and consumption to maintain energy balance.
The AMP-activated protein kinase (AMPK) and mechanistic target of rapamycin (mTOR) pathways sense ATP/AMP ratios and regulate ATP-producing and ATP-consuming processes. In pancreatic beta cells, ATP metabolism is coupled to insulin secretion via ATP-sensitive potassium channels and calcium signaling. In inflammatory macrophages, one-carbon metabolism supports S-adenosylmethionine and histone methylation, which are ATP-dependent processes. Purinergic signaling between adipocytes and macrophages can promote degeneration of thermogenic brown adipose tissue, linking ATP metabolism to energy expenditure.
Key Genes Involved in GO:0046034 ATP metabolic process
The following genes encode enzymes and regulators that are central to ATP metabolic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HK2 | Hexokinase 2, first step of glycolysis | Overexpressed in many cancers; target for glycolytic inhibition |
| PFKM | Phosphofructokinase, rate-limiting step of glycolysis | Key regulatory node in ATP production; mutations cause glycogen storage disease |
| PKM | Pyruvate kinase, final step of glycolysis | Isoform switch (PKM2) promotes Warburg effect in cancer |
| ATP5F1A | ATP synthase alpha subunit, mitochondrial ATP synthesis | Essential for oxidative phosphorylation; target in cancer metabolism |
| ATP5F1B | ATP synthase beta subunit, catalytic core | Mutations linked to mitochondrial disorders |
| ATP1A1 | Na+/K+-ATPase alpha subunit, ATP hydrolysis for ion transport | Regulates cellular energy demand; target in cancer and neurological disorders |
| IDH2 | Isocitrate dehydrogenase 2, mitochondrial NADPH and ATP support | Wild-type IDH2 is a therapeutic target in triple-negative breast cancer |
| AMPK | Energy sensor, activates ATP-producing pathways | Central regulator of energy homeostasis; target for diabetes and cancer |
| mTOR | Growth regulator, promotes ATP-consuming biosynthesis | Integrates nutrient and energy signals; target in cancer and metabolic disease |
| SLC2A1 | GLUT1 glucose transporter, supplies substrate for glycolysis | Overexpressed in cancer and required for high ATP demand |
| LDHA | Lactate dehydrogenase A, regenerates NAD+ for glycolysis | Supports glycolytic ATP production in cancer |
| PDK1 | Pyruvate dehydrogenase kinase 1, inhibits PDH | Shifts metabolism toward glycolysis and lactate production |
| ATP2A2 | SERCA calcium pump, uses ATP for calcium sequestration | Regulates calcium signaling and ATP consumption |
| ATP6V1A | V-ATPase subunit, ATP-driven proton transport | Important for lysosomal function and mTOR signaling |
| MAT2A | Methionine adenosyltransferase, produces SAM from ATP | Links ATP metabolism to epigenetic regulation in macrophages |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase, glycolytic enzyme | Also has non-glycolytic roles; target for metabolic studies |
| ENO1 | Enolase 1, glycolytic enzyme | Overexpressed in cancer; potential biomarker |
| UCP1 | Uncoupling protein 1, dissipates proton gradient as heat | Central to thermogenesis in brown adipose tissue |
How Is ATP metabolic process Regulated?
ATP metabolic process is regulated at multiple levels. Energy sensors such as AMPK and mTOR coordinate ATP production with consumption in response to nutrient and hormonal signals. Substrate availability (glucose, oxygen, fatty acids) directly influences flux through glycolysis and oxidative phosphorylation. In pancreatic beta cells, ATP/ADP ratio controls insulin secretion via ATP-sensitive potassium channels. Inflammatory macrophages rely on one-carbon metabolism to support S-adenosylmethionine and histone methylation, which are ATP-dependent. Purinergic signaling between adipocytes and macrophages can modulate thermogenesis and ATP demand in brown adipose tissue. Additionally, electron bifurcation in microbes provides a mechanism for energy conservation that impacts ATP synthesis.
ATP metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HK2 | Cancer (glycolytic dependency) | Knockout in cancer cell lines; xenograft models |
| IDH2 | Triple-negative breast cancer | Knockout or point mutation (IDH2 R140Q) in breast cancer cells |
| ATP1A1 | Neurological disorders, cancer | Point mutation (e.g., ouabain resistance) in cell lines |
| UCP1 | Obesity, thermogenesis | Knockout in brown adipocytes; overexpression in white adipocytes |
| MAT2A | Inflammatory diseases | Knockout in macrophages; point mutation of catalytic residue |
Cancer metabolism and the Warburg effect
Many cancer cells reprogram ATP metabolism toward aerobic glycolysis, known as the Warburg effect, to support rapid ATP production and biosynthesis. This shift is associated with overexpression of glycolytic enzymes such as HK2, PFKM, and PKM, and provides targets for therapeutic intervention. Wild-type IDH2 supports mitochondrial ATP production and redox balance in triple-negative breast cancer, and its inhibition impairs tumor growth.
Diabetes and insulin secretion
ATP metabolic process is essential for glucose-stimulated insulin secretion in pancreatic beta cells. ATP generated from glucose metabolism closes ATP-sensitive potassium channels, leading to membrane depolarization and insulin release. Dysregulation of this process contributes to type 2 diabetes, and targeting ATP metabolism is a strategy for improving beta cell function.
Obesity and thermogenesis
Purinergic crosstalk between adipocytes and macrophages promotes degeneration of thermogenic brown adipose tissue, linking ATP metabolism to energy expenditure and obesity. UCP1 dissipates the proton gradient to generate heat, and its activity is influenced by ATP metabolism.
Inflammatory and immune disorders
One-carbon metabolism supports S-adenosylmethionine and histone methylation to drive inflammatory macrophage activation, a process that depends on ATP. Targeting ATP metabolic pathways may modulate immune responses in inflammatory diseases.
From ATP metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HK2 impair tumor growth? | HK2 knockout in cancer cell lines and mouse xenografts |
| Does mutant IDH2 affect ATP production? | IDH2 point mutation (R140Q) knock-in in breast cancer cells |
| How does ATP1A1 mutation alter ion transport? | ATP1A1 point mutation knock-in in HEK293 cells |
| Can overexpression of UCP1 enhance thermogenesis? | UCP1 overexpression in brown adipocytes |
| What is the role of MAT2A in macrophage inflammation? | MAT2A knockout or catalytic-dead knock-in in macrophages |
| Does ATP synthase subunit tagging affect mitochondrial function? | ATP5F1A tagged knock-in in HeLa cells |
How to Study the ATP metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Seahorse XF | Oxygen consumption and extracellular acidification | Assess oxidative phosphorylation and glycolysis in live cells |
| ATP luminescence | Total cellular ATP | Quantify ATP levels after gene knockout or drug treatment |
| CRISPR screen | Gene essentiality for ATP metabolism | Identify metabolic vulnerabilities in cancer |
| Metabolomics | Steady-state metabolite levels | Profile glycolytic and TCA cycle intermediates |
| Isotope tracing | Metabolic flux | Measure pathway activity in vitro and in vivo |
| Western blot | Protein expression of ATP metabolic enzymes | Validate knockout or overexpression efficiency |
| qRT-PCR | mRNA levels of ATP metabolic genes | Assess transcriptional changes |
| Immunofluorescence | Subcellular localization of ATP metabolic proteins | Study mitochondrial ATP synthase assembly |
Seahorse extracellular flux analysis
Seahorse XF analyzers measure oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) to assess oxidative phosphorylation and glycolysis in live cells. This method is widely used to evaluate ATP production pathways in cancer and immune cells.
ATP luminescence assays
Luciferase-based ATP assays quantify total cellular ATP levels and can be used to measure changes in ATP metabolic process after genetic or pharmacological perturbations. These assays are rapid and suitable for high-throughput screening.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes essential for ATP metabolism under specific conditions, such as hypoxia or nutrient deprivation. Such screens have revealed metabolic vulnerabilities in cancer.
Metabolomics and flux analysis
Mass spectrometry-based metabolomics and isotope tracing measure metabolite levels and flux through ATP-producing pathways. These techniques provide a systems-level view of ATP metabolism.
How CRISPR Can Be Used to Study GO:0046034 ATP metabolic process
Knockout
CRISPR knockout of genes such as HK2, PFKM, or ATP5F1A can abolish specific ATP production pathways, revealing their contribution to cellular energy homeostasis. Knockout models are essential for validating metabolic targets in cancer and diabetes research.
Point Mutation
Point mutations in ATP metabolic genes, such as IDH2 R140Q or ATP1A1 mutations, can mimic disease-associated alleles and help dissect their impact on ATP production and ion transport. CRISPR point mutation models are valuable for studying enzyme kinetics and drug resistance.
Knock-in
Knock-in of tagged ATP synthase subunits (e.g., ATP5F1A-HA) allows visualization and immunoprecipitation of mitochondrial complexes, facilitating studies of ATP synthase assembly and function. Knock-in of reporter genes can also track ATP levels in real time.
Overexpression
Overexpression of glycolytic enzymes such as PKM2 or UCP1 can enhance or uncouple ATP production, respectively, providing models to study metabolic reprogramming and thermogenesis. CRISPR activation (CRISPRa) enables targeted overexpression without exogenous constructs.
How EDITGENE Supports ATP metabolic process Research
Researchers studying ATP metabolic process-related genes often need to determine whether a candidate gene is causally involved in ATP production, utilization, or regulation. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling rigorous functional studies of ATP metabolism in health and disease.
Contact EDITGENE today to design your custom CRISPR model for ATP metabolic process research.
Frequently Asked Questions About ATP metabolic process
What is ATP metabolic process?
ATP metabolic process (GO:0046034) encompasses all chemical reactions and pathways involving ATP, including its synthesis via glycolysis and oxidative phosphorylation, and its utilization in cellular work.
What genes are involved in ATP metabolic process?
Key genes include glycolytic enzymes (HK2, PFKM, PKM), mitochondrial ATP synthase subunits (ATP5F1A, ATP5F1B), ion pumps (ATP1A1), and metabolic regulators (IDH2, AMPK, mTOR).
How is ATP produced in cells?
ATP is produced primarily through glycolysis in the cytoplasm and oxidative phosphorylation in mitochondria, with additional contributions from substrate-level phosphorylation.
What is the Warburg effect?
The Warburg effect is the observation that cancer cells often rely on aerobic glycolysis for ATP production even in the presence of oxygen, supporting rapid growth and biosynthesis.
How does ATP metabolism relate to insulin secretion?
In pancreatic beta cells, ATP generated from glucose metabolism closes ATP-sensitive potassium channels, triggering calcium influx and insulin release.
Can CRISPR be used to study ATP metabolism?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise manipulation of ATP metabolic genes to study their function and disease relevance.
What diseases are linked to ATP metabolic process?
Dysregulated ATP metabolism is linked to cancer, type 2 diabetes, obesity, inflammatory diseases, and neurodegenerative disorders.
What methods measure ATP metabolism?
Common methods include Seahorse extracellular flux analysis, ATP luminescence assays, metabolomics, and isotope tracing.
What is the role of IDH2 in ATP metabolism?
Wild-type IDH2 supports mitochondrial ATP production and redox balance, and its inhibition is a therapeutic strategy in triple-negative breast cancer.
How does one-carbon metabolism relate to ATP?
One-carbon metabolism supports S-adenosylmethionine and histone methylation, processes that depend on ATP, in inflammatory macrophages.
Conclusion
ATP metabolic process (GO:0046034) is a central biological process that governs energy production and utilization in all cells. Its dysregulation underlies major human diseases, including cancer, diabetes, and obesity, making it a rich area for therapeutic targeting. Advances in CRISPR-based genome editing and metabolic profiling now allow researchers to dissect the precise roles of individual genes in ATP metabolism with unprecedented resolution. Continued investigation of this process will yield new insights into cellular bioenergetics and disease mechanisms.
References
- 1. Ganapathy-Kanniappan S et al.. 2013. Tumor glycolysis as a target for cancer therapy: progress and prospects.. Mol Cancer 12:152 PMID: 24298908
- 2. Yu W et al.. 2019. One-Carbon Metabolism Supports S-Adenosylmethionine and Histone Methylation to Drive Inflammatory Macrophages.. Mol Cell 75(6):1147-1160.e5 PMID: 31420217
- 3. Merrins MJ et al.. 2022. Metabolic cycles and signals for insulin secretion.. Cell Metab 34(7):947-968 PMID: 35728586
- 4. Li JJ et al.. 2024. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer.. Nat Commun 15(1):3445 PMID: 38658533
- 5. Mohan G et al.. 2026. Introduction to Cancer Metabolism.. Cancer Treat Res 195:1-20 PMID: 42144517
- 6. Hädicke O et al.. 2015. Manipulation of the ATP pool as a tool for metabolic engineering.. Biochem Soc Trans 43(6):1140-5 PMID: 26614651
- 7. Jaeckstein MY et al.. 2025. Purinergic adipocyte-macrophage crosstalk promotes degeneration of thermogenic brown adipose tissue.. EMBO Rep 26(24):6460-6493 PMID: 41261284
- 8. Müller V et al.. 2018. Electron Bifurcation: A Long-Hidden Energy-Coupling Mechanism.. Annu Rev Microbiol 72:331-353 PMID: 29924687
